Atlas Trials

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

Clinical trial NCT06822946 · RECRUITING

Trial details

NCT number
NCT06822946
Sponsor
Chengdu Diao Jiuhong Pharmaceutical Factory
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Hyperlipidemia
Start date
2025-03-27
Primary completion
2026-02-28
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.